Clinical Data chief executive Drew Fromkin argues that the nature of the depression market is changing as more and more drugs go generic, with branded drugs being prescribed increasingly by specialists.
Fromkin is much too dismissive of the growing role of religion in modern America, for instance, and he is overly sympathetic to the notion of world government and to the overblown fears of environmental apocalypse.